Aptus Pharma
add_icon

Aptus Pharma

271.95
-271.95
(-100.00%)
Market Cap
186.60 Cr
PE Ratio
-
Volume
0.00
Day High - Low
- - -
52W High-Low
271.95 - 80.80
ann
There are new updates from the company20 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
186.60 Cr
EPS
6.37
PE Ratio
-
PB Ratio
9.33
Book Value
29.13
EBITDA
4.90
Dividend Yield
0.00 %
Return on Equity
44.50
Debt to Equity
1.79
Forecast For
Actual

Company News

View All News
Caret
positive
Aptus Pharma Limited announces strategic business expansion into Life-Saving Injectables and ICU Care product category, targeting critical care conditions and hospital settings.
positive
Aptus Pharma Limited receives recognition as 'Fastest Growing Ethical Pharma Company' from News 18 Group, with award presented by Gujarat's Deputy Chief Minister Harsh Sanghavi.
positive
Aptus Pharma Limited disseminates comprehensive investor presentation to analysts covering business operations and financial performance under SEBI regulations, highlighting company's growth trajectory and strategic vision.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,588.60
#1 1,07,829.78
60.56
#1 24,630.60
14.26
#1 2,203
-61.57
59.73
1,576.40
52,160.67
103.89
15,737.30
23.58
834
-35.40
62.64
1,955.70
40,212.08
81.80
12,042.70
23.73
591
-39.17
60.14
7,990.50
28,104.22
152.82
10,046.60
#1 48.08
251
-125.14
71.54
258.38
16,637.47
35.80
7,932.40
7.48
564
-9.74
56.82
315.15
13,751.40
47.88
5,598.70
14.48
314
-5.15
43.03
922.15
11,699.49
#1 34.28
8,110.20
15.97
363
-39.55
54.42
477.45
9,234.06
58.31
2,451.50
11.53
164
-71.43
30.91
523.00
7,162.54
92.32
2,789.50
1.31
108
-44.50
31.86
817.20
5,611.83
35.89
1,622.70
34.46
213
#1 300.00
38.66
Growth Rate
Revenue Growth
37.43 %
Net Income Growth
287.50 %
Cash Flow Change
15.21 %
ROE
-1.51 %
ROCE
105.69 %
EBITDA Margin (Avg.)
127.53 %

Yearly Financial Results

Annual Financials
2023
2024
2025
TTM
Revenue
14
18
25
0
Expenses
13
16
20
0
EBITDA
1
2
5
0
Operating Profit %
4 %
9 %
20 %
0 %
Depreciation
0
0
0
0
Interest
0
0
1
0
Profit Before Tax
0
1
4
0
Tax
0
0
1
0
Net Profit
0
1
3
0
EPS in ₹
1.30
5.32
6.37
0.00

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
6
10
22
Fixed Assets
1
1
1
Current Assets
6
8
20
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
6
9
21
Total Liabilities
6
10
22
Current Liabilities
3
4
12
Non Current Liabilities
2
4
3
Total Equity
1
2
7
Reserve & Surplus
1
2
2
Share Capital
0
0
5

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
0
0
4
Investing Activities
-0
-0
-1
Operating Activities
-0
-2
-2
Financing Activities
1
3
7

Share Holding

% Holding
Jun 2025
Sept 2025
Dec 2025
Promoter
72.89 %
72.89 %
72.89 %
FIIs
10.03 %
10.03 %
0.00 %
DIIs
2.80 %
2.80 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
11.55 %
11.55 %
22.97 %
Others
2.74 %
2.74 %
4.14 %
No of Share Holders
9
9
302

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Nov 2025 129.20 145.50

Technical Indicators

RSI(14)
Neutral
73.21
ATR(14)
Less Volatile
5.95
STOCH(9,6)
Overbought
93.82
STOCH RSI(14)
Neutral
71.73
MACD(12,26)
Bearish
-0.11
ADX(14)
Strong Trend
30.13
UO(9)
Bearish
84.15
ROC(12)
Uptrend And Accelerating
8.05
WillR(14)
Overbought
0.00